IRF1 demonstrated direct binding to VEGFR2 (but not VEGFR1), inhibited the PI3K/Akt signaling pathway and eNOS phosphorylation, and prevented tumor growth and angiogenesis in vivo. The gene discussed is IRF1; the disease is neoplasm.